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T helper 17 (Th17) cells specifically transcribe the
Il17 and Il17f genes, which are localized in the same
chromosome region, but the underlying mechanism
is unclear. Here, we report a cis element that we
previously named conserved noncoding sequence
2 (CNS2) physically interacted with both Il17 and
Il17f gene promoters andwas sufficient for regulating
their selective transcription in Th17 cells. Targeted
deletion of CNS2 resulted in impaired retinoic acid-
related orphan receptor gammat (RORgt)-driven
IL-17 expression in vitro. CNS2-deficient T cells
also produced substantially decreased amounts of
IL-17F. These cytokine defects were associated
with defective chromatin remodeling in the Il17-Il17f
gene locus, possibly because of effects on CNS2-
mediated recruitment of histone-modifying enzymes
p300 and JmjC domain-containing protein 3
(JMJD3). CNS2-deficient animals were also shown
to be resistant to experimental autoimmune enceph-
alomyelitis (EAE). Our results thus suggest that
CNS2 is sufficient and necessary for Il17 and optimal
Il17f gene transcription in Th17 cells.
INTRODUCTION
In contrast to the effector CD4+ T helper 1 (Th1) and Th2 cells that
produce interferon-g (IFN-g) and interleukin 4 (IL-4), respectively,
Th17 cells uniquely produce two related effector cytokines, IL-17
and IL-17F, and these cytokines have been shown to be impor-
tant in immunity against bacteria and fungi (Korn et al., 2009).
However, because of the powerful proinflammatory activities
conferred by IL-17 and IL-17F, Th17 cells also potently induce
or maintain tissue inflammation and can cause many inflamma-
tory and autoimmune diseases, including multiple sclerosis
(MS), asthma, rheumatoid arthritis (RA), and inflammatory bowl
diseases (IBD) (Dong, 2008; Korn et al., 2009). Therefore, the
transcriptional regulation of the Il17 and Il17f genes has attracted
much attention recently.The Il17 and Il17f genes are encoded at the same chromo-
somal locus. They are separated by 43.9 kb in mice and are
transcribed in opposite directions. Th17 cell differentiation
requires IL-6 and transforming growth factor (TGF)-b (Dong,
2008; Korn et al., 2009), and IL-1 is also important in regulating
early Th17 cell differentiation (Chung et al., 2009). These cyto-
kines, together with T cell receptor signaling, lead to activation
of signal transducer and activator of transcription 3 (STAT3),
interferon regulatory factor 4 (IRF4), retinoic acid-related orphan
receptor (ROR)gt, RORa, Runt-related transcription factor 1
(RUNX1), B cell-activating transcription factor (Batf), and
IkappaBz (IkBz) (Chen et al., 2006; Ivanov et al., 2006; Okamoto
et al., 2010; Schraml et al., 2009; Yang et al., 2008b; Zhang et al.,
2008). Among these transacting factors, RORgt is identified as
the ‘‘master regulator’’ in Th17 cells and is both necessary and
sufficient for IL-17 and IL-17F expression (Ivanov et al., 2006).
RORa plays redundant and synergistic functions with RORgt
(Yang et al., 2008b). Despite these studies on trans-acting
factors, their target cis-acting elements in driving selective
Th17-specific cytokine expression are poorly understood.
cis-acting regulatory elements are often conserved across
species (Meireles-Filho and Stark, 2009) and have been shown
to be crucial in controlling T cell differentiation. In Th2 cells, the
effector cytokine genes are controlled by a conserved noncod-
ing sequence (CNS) 1 located between the Il4 and Il13 genes,
a locus control region (LCR) between the Il13 and Il5 genes, an
intronic enhancer HS2 within the Il4 gene, and several other cis
elements (Lee et al., 2001; Solymar et al., 2002; Tanaka et al.,
2011). Targeted deletion of these cis elements impairs the
expression of Th2 cytokines in vitro and in vivo (Loots et al.,
2000; Lee et al., 2005; Tanaka et al., 2011). In regulatory T
(Treg) cells, the stability, frequency, and tissue- or organ-specific
development of forkhead box P3 (FOXP3+) T cells are controlled
by three different noncoding sequences, CNS1–CNS3 (Zheng
et al., 2010). The expression of IFN-g in Th1 cells may be
controlled predominantly by a T-bet-dependent enhancer
CNS22, a conserved sequence located 22 kb upstream of the
Ifng gene, based on studies with a transgenic model (Hatton
et al., 2006). In T cell development, one important feature of
cis-acting regulatory elements is that they undergo permissive
chromatin remodeling in a lineage-specific manner, thereby al-
lowing the binding of various trans-acting factors for selectiveImmunity 36, 23–31, January 27, 2012 ª2012 Elsevier Inc. 23
Figure 1. CNS2 Was Sufficient to Regulate
Lineage-Specific Il17 and Il17f Gene Transcription
(A) The luciferase activities of the PGL3, IL-17 promoter
(17p)-PGL3, IL-17F promoter (17Fp)-PGL3, CNS2-17p-
PGL3, and CNS2-17Fp-PGL3 reporter constructs in Th1
and Th17 cells. In CNS2-17p-PGL3 vector, two putative
ROR binding sites were mutated and the mutant reporter
was designated as RORmu-PGL3. Shown here are the
combinational results from two to three biological replicas.
Data shown as mean ± SD (standard deviation).
(B) The interaction of CNS2 with the Il17 and 17f promoters
wasdetermined inTh1andTh17cellsby3Canalysis.C57BL/
6J mouse genomic DNA was used as a negative control
for PCR. Shown here is one of three representative results.
See also Figure S1.
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Requirement of CNS2 in Il17 Gene Transcriptiongene transcription. Additionally, the distal cis-regulatory
elements may interact with the cytokine gene promoters by
forming a three-dimentional loop, which therefore provides
a platform capable of initiating gene transcription by bringing
together trans-acting factors to a close spatial proximity, such
as the cis-regulatory loop formed at the Th2 cytokine gene locus
(Spilianakis and Flavell, 2004).
To characterize the mechanism underlying lineage-specific
expression of IL-17 and IL-17F, we previously identified a total
of eight conserved noncoding sites (CNS) in the Il17-Il17f locus
by sequence comparison and found at least several of them,
including CNS2, were associated with hyperacetylated histone
H3, a marker of permissive chromatin structure (Wilson et al.,
2009), in Th17 cells (Akimzhanov et al., 2007). The lineage-
specific chromatin remodeling of CNS2 and the Il17-Il17f locus
was recently confirmed by global mapping histonemodifications
in different T helper cells (Wei et al., 2009). Interestingly, we
observed that CNS2 functioned to promote the activation of
Il17 gene promoter possibly through binding to ROR factors
(Yang et al., 2008b). In addition, CNS2 may also interact with
other Th17 cell-regulating transcription factors (Okamoto et al.,
2010; Schraml et al., 2009; Zhang et al., 2008). These in vitro
data together suggest that CNS2 may be important in regulating
IL-17 expression in vivo. In this study, we generated CNS2-defi-
cient mice by homologous recombination. With these mice, the
role of CNS2 and the underlying mechanism in regulating IL-17
and IL-17F expression and Th17 cell differentiation was evalu-
ated in both in vitro and in vivo systems.
RESULTS
CNS2 Regulated the Lineage-Specific Transcription
of Both Il17 and Il17f Genes
To test whether CNS2 functions as a lineage-specific regulatory
element, we first assessed whether it was bound by p300,
because p300 binding has recently shown to predict enhancer
elements in the genome (Visel et al., 2009). We therefore per-
formed a chromatin immunoprecipitation (ChIP) assay with an
antibody to p300. CNS2 was bound by p300 specifically in
Th17 but not in Th1 cells whereas the Ifng promoter (IFN-gp)
interacted with p300 only in Th1 cells (Figure S1A available
online).
The regulation of IL-17 by CNS2 has been suggested by
luciferase reporter assays in EL4 and Jurkat cells (Yang et al.,
2008b; Zhang et al., 2008). To further test whether CNS224 Immunity 36, 23–31, January 27, 2012 ª2012 Elsevier Inc.dictates Th17 cell-specific transcription of the Il17 and Il17f
genes, we developed a luciferase reporter assay in primary
T cells. Whereas the Il17 or Il17f gene promoter did not exhibit
substantially increased activation in Th17 compared to Th1
cells, addition of CNS2 increased the Il17 promoter activity by
approximately 9.5-fold in Th17 but not Th1 cells (Figure 1A). In
addition, CNS2 also increased the cell type-specific Il17f
promoter activity (Figure 1A). These results suggest that CNS2
is sufficient in driving lineage-specific transcription of the Il17
and Il17f genes. To examine whether the role of CNS2 is depen-
dent on binding by ROR factors, the two ROR-binding sites
(RORE) predicted in the CNS2 region were mutated, which
consistently led to 50% reduction of the promoter activity
of the CNS2-Il17 reporter construct (Figure 1A), although it
completely lost ROR-mediated transcription in EL4 cells (Fig-
ure S1B), excluding the presence of additional RORE sites in
the CNS2 region.
Interestingly, we found that CNS2, when fused to the Ifng or Il4
promoters, robustly induced their transcription in Th17 cells, and
even in EL4 or 293T cells (Figures S1C–S1E), indicating that
CNS2 can function independent of Il17 or Il17f gene promoter
to regulate Th17 cell-specific transcription. Taken together,
these results suggest that CNS2 is sufficient in mediating
lineage-specific transcription of Il17 and Il17f genes, possibly
by serving as an enhancer element.
CNS2 Interacted with Both the Il17 and Il17f Promoters
in Th17 Cells
CNS2 is located 2 kb upstream of the Il17 gene promoter and
56.5 kb away from the Il17f gene in mice (Akimzhanov et al.,
2007). To investigate the mechanism underlying this long-
distance regulation, we performed a chromosome conformation
capture (3C) assay—a powerful technology that can detect long-
range intra- or interchromosomal associations between distantly
related DNA elements (Tolhuis et al., 2002). In this technique,
DNA-protein complexes are covalently crosslinked by formalde-
hyde or paraformaldehyde. After restriction enzyme digestion,
DNA fragments crosslinked together in the same complex can
be preferentially ligated together when diluted to a very low
concentration, which can be detected by PCR amplification. In
Th17 but not Th1 cells, we found that the 50-end of CNS2 can
be directly ligated to the 30-end of Il17p based on the size of
PCR product (Figure 1B). Moreover, a strong association of
CNS2 with the Il17fp was also observed (Figure 1B). The cell
type-specific association with the Il17 and Il17f promoters
Figure 2. Impaired Expression of IL-17 and
IL-17F In Vitro in the Absence of CNS2
(A) Th17 cells were generated in vitro with naive
T cells from WT and CNS2-deficient (hereafter
referred to as KO in the figure) mice under
optimal Th17 cell conditions (IL-6+TGF-b+IL-
1b+IL-23+TNF-a).
(B) Th17 cells were generated under suboptimal
Th17 cell conditions (IL-6+TGF-b).
The expression of IL-17 and IL-17F was deter-
mined by intracellular staining. Th0 cells were
used as a staining control. Statistical analysis of
the intracellular data is shown on the right. See
also Figure S2.
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Requirement of CNS2 in Il17 Gene Transcriptionfurther suggests an important role of CNS2 in regulating lineage-
specific Il17 and Il17f gene transcription.
CNS2 Was Required for IL-17 and Optimal IL-17F
Expression in Th17 Cells Generated In Vitro
The importance of CNS2 in the control of IL-17 and IL-17F gene
expression has thus far been highlighted by luciferase reporter
assays and 3C analysis. To further test the function of CNS2
genetically, CNS2-deficient mice were generated by homolo-
gous recombination and the neomycin-selecting gene was
subsequently removed by loxp-cre system to avoid its influence
over transcription of endogenous genes (Figure S2A). The dele-
tion of CNS2 in mice was confirmed by PCR (Figure S2B).
Naive CD4+ T cells were isolated from both the CNS2 wild-
type (WT) and CNS2-deficient mice and polarized into various
effector Th cells. The gene expression pattern of these effector
T cells was then analyzed by different assays including intracel-
lular staining, real-time RT-PCR, and ELISA (enzyme-linked
immunosorbent assay). CNS2-deficient T cells expressed less
than 10% IL-17 and less than 30%–55% IL-17F compared
with the WT cells under different Th17 cell conditions (Figures
2, S2C, and S2D), although they displayed normal Th1, Th2,
and iTreg cell differentiation (Figure S2E). The expression of
other Th17 cell-related genes, including ROR factors and IL-
21, was not affected in CNS2-deficient cells (Figure S2C). These
data indicate that CNS2 functions downstream of RORs in
mediating the Il17 and Il17f gene transcription. To ascertain
this, ROR factors were retrovirally overexpressed in both WT
and CNS2-deficient T cells cultured under Th0 and Th17 cell
conditions. Remarkably, overexpression of ROR factors even
under Th17 cell-polarized condition could not lead to any notice-
able expression of IL-17 in CNS2-deficient cells (Figures 3A and
3B). In addition, a strong reduction in IL-17F expression was also
observed in CNS2-deficient cells (Figures 3A and 3B). This result
suggests that CNS2 is required for the function of ROR factors in
mediating IL-17 expression in Th17 cells.
CNS2 Controlled Chromatin Accessibility
at the Il17-Il17f Locus
To understand the possible mechanism whereby CNS2 func-
tions to regulate Il17 and Il17f gene transcription, we examinedthe binding of RNA polymerase II (Pol II) to the Il17p and Il17fp
in WT and CNS2-deficient Th17 cells and found that both
CNS2 and the Il17 and Il17f promoters interacted with Pol II in
WT Th17 cells. Consistent with the findings that CNS2 was
more important for Il17 than Il17f gene transcription (Figures 2,
S2C, and S2D), deletion of CNS2 greatly reduced the binding
of RNA Pol II to the Il17 promoter whereas the binding to the
Il17f promoter was only partially affected (Figure 4A).
To assess whether the chromatin accessibility at the Il17-Il17f
gene locus may be altered by the absence of CNS2, a ChIP
assay was performed with antibodies against acetyl histone H3
(H3Ac) and K27-trimethylated histone (H3K27me3) in Th17 cells.
In the Il17 promoter region, permissive histonemarker H3Ac was
significantly reduced in CNS2-deficient cells along with
increased presence of repressive histone marker H3K27me3
(Figure 4B; Wilson et al., 2009). In addition, chromatin remodel-
ing was also affected, though to a lesser extent, in the Il17f
promoter region and other CNS sites (Figure 4B). The results
here thus suggest that chromatin remodeling of the Il17-Il17f
locus is at least partially dependent on CNS2. Moreover, the
extent of the altered chromatin structures caused by CNS2
deficiency at the respective promoter regions was consistent
with the level of cytokine expression.
To further understand how CNS2 regulates chromatin acces-
sibility, we examined the binding of several histone remodeling
enzymes to CNS2 and to the Il17-Il17f promoter regions and
found that CNS2 interacted with p300 and JmjC domain-con-
taining protein 3 (JMJD3) in Th17 cells (Figure 4C). p300 contains
histone acetyltransferases (HAT) activity and mediates permis-
sive histone acetylation (Wang et al., 2008); JMJD3 has been
identified as a histone demethylase that specifically removes
repressive histone marker H3K27me3 (Agger et al., 2007; De
Santa et al., 2007; Xiang et al., 2007). Considering CNS2 associ-
ation with both the Il17 and Il17f promoters as shown by our 3C
analysis, binding of these histone remodeling enzymes to CNS2
may increase their localization near the promoters and therefore
increase locus-specific enzymatic activity. Interestingly, deletion
of CNS2 significantly decreased the binding of p300 to the Il17
promoter but less to the Il17f promoter in Th17 cells (Figure 4C).
Previous ChIP and electrophoretic mobility shift (EMS) assays
suggest that RORgt physically interacted with CNS2 (Yang et al.,Immunity 36, 23–31, January 27, 2012 ª2012 Elsevier Inc. 25
Figure 3. CNS2 Was Required for ROR-
Regulated Th17 Cell Differentiation
(A) WT and CNS2-deficient T cells cultured under
Th0 and Th17 cell conditions were infected
with retroviruses RORa-hCD2, RORgt-hCD2, or
empty-hCD2 on day 1 and analyzed on day 4
(gated on hCD2+ cells).
(B) Statistics of the intracellular staining data from
three independent retroviral assays (mean ± SD).
The percentage values from CNS2-deficient cells
were set as 1 for comparison between biological
replicates.
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Requirement of CNS2 in Il17 Gene Transcription2008b; Zhang et al., 2008). In our retroviral overexpression
assays, we found that CNS2 was functionally required for
ROR-dependent IL-17 expression in Th17 cells (Figure 3). To
further understand the mechanism underlying CNS2-dependent
IL-17 transcription, we investigated the role of RORg in chro-
matin activation of the Il17-Il17f gene locus. We found that the
Il17 promoter showed a hallmark of ‘‘closed’’ chromatin struc-
ture in RORg-deficient Th17 cells characterized by greatly
reduced H3Ac and increased H3K27me3 (Figure S3). However,
the Il17fp region was only mildly affected by the deletion of
RORg (Figure S3). The RORgt-deficient Th17 cells thus dis-
played a similar, although not identical, phonotype to that of
CNS2-deficient Th17 cells (Figures 4B and S3).
Our results altogether support amodel that RORgt (and RORa)
binds to CNS2 and initiates chromatin remodeling at Il17-Il17f
locus, in which CNS2 provides a necessary binding site for
RORgt to activate the transcription of the Il17 gene.
CNS2 Differentially Regulated IL-17 and IL-17F
Production in Different Types of Immune Cells In Vivo
IL-17 and IL-17F can be expressed not only by Th17 cells but
also by innate or innate-like immune cells, such as gd T and
lymphoid tissue inducer (LTi) or LTi-like cells (Cua and Tato,
2010). We first examined memory CD4+ T cells and found that
CNS2 deficiency impacted IL-17 and IL-17F expression in
a similar manner as in Th17 cells generated in vitro (Figures 5
and S4). Th17 cells are also abundant in gut-associated
lymphoid tissues and are suggested to play an important role
in mucosal immunity or immune homeostasis in the gut (Cua
and Tato, 2010; Ivanov et al., 2006). We therefore isolated
laminal propria (LP) cells and intestinal intraepithelial lympho-
cytes (IELs) from the intestinal tissues of healthy WT and
CNS2-deficient mice for intracellular staining analysis. To our
surprise, CNS2 was required for optimal expression of IL-1726 Immunity 36, 23–31, January 27, 2012 ª2012 Elsevier Inc.protein but not for IL-17F, which even
showed increased expression in CNS2-
deficient cells (Figure S5A).
To determine whether CNS2 also regu-
lates the expression of IL-17 and IL-17F in
innate immune cells, gd T and LTi-like
cells were isolated from the spleens in
healthy CNS2-deficient mice and their
WT control mice and then analyzed for
Th17 cell-related gene expression after
ex vivo restimulation. In contrast to Th17cells, CNS2 did not greatly alter the frequency of IL-17+ express-
ing cells in either gd T or LTi-like cells (Figure 5). Instead, deletion
of CNS2 led to substantially reduced per-cell protein level of
IL-17 as judged by media fluorescence intensity (MFI) of IL-17
staining, with similar effects at the mRNA level (Figures 5 and
S4). In addition, we found that CNS2 was no longer required
for IL-17F expression in both gd T and LTi-like cells and deletion
of CNS2 even led to its increased expression (Figures 5 and S4).
These results suggest that CNS2 differentially controls IL-17
and IL-17F expression in not only Th17 cells but also between
adaptive and innate immune cells.
CNS2-Deficient Mice Were Resistant to Experimental
Autoimmune Encephalomyelitis
To further understand the function of CNS2 during in vivo
immune responses, we first examined the role of CNS2 in an
allergic lung inflammation model by intranasally challenging
mice with an allergenic fungal proteinase (FAP) derived from
Aspergillus oryzae as described (Kiss et al., 2007; Yang et al.,
2008a). As expected, IL-17F expression was not impaired in
lung tissues and lung gd T cells and was even increased in the
absence of CNS2 (Figures 6A, S5B, and S5C). Accordingly, we
observed more neutrophils infiltrating the brondchoalveolar
lavage (BAL) of CNS2-deficient mice (Figure S5D).
To understand the role of CNS2 in Th17 cell generation in vivo,
we immunized mice with MOG35-55 peptide and found that the
number and frequency of MOG-specific IL-17+ Th17 cells were
greatly reduced in both the spleens and draining lymph nodes
of CNS2-deficient mice (Figure 6B). To further test the con-
tribution of CNS2 in the development of Th17 cell-dependent
autoimmune diseases, both WT and CNS2-deficient mice were
subjected to myelin oligodendrocyte glycoprotein (MOG)
peptide-induced experimental autoimmune encephalomyelitis
(EAE)—an autoimmune mouse disease model that closely
Figure 4. CNS2 Controlled the Chromatin Accessi-
bility in the Il17-Il17f Gene Locus
The ChIP assays were performed with WT and CNS2-
deficient Th17 cells with different antibodies. The binding
of antibodies to the Il17-Il17f gene locus was detected by
real-time PCR. When indicated, the Ifng gene promoter
(IFN-gp) or Il22 promoter (IL22p) or IgG ChIP signal in WT
Th17 cells were used as negative controls for real-time
PCR assays.
(A) Anti-RNA Pol II ChIP assay.
(B) Anti-H3Ac and anti-H3K27me3 ChIP assays. The
results were normalized to the input control and the overall
change of chromatin accessibility was evaluated by using
the ratio of histone markers H3Ac/H3K27me3. Shown
here is one of three representative results.
(C) Anti-p300 and anti-JMJD3 ChIP assays. The assay
performed with anti-RNA Pol II, p300, or JMJD3 is shown
as the combinational result from two to three independent
experiments and the data from each replicate were
normalized to the average IgG ChIP signals in WT and
CNS2-deficient Th17 cells for comparison across biolog-
ical replicates.
All data shown as mean ± SD. See also Table S1 and
Figure S3.
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Requirement of CNS2 in Il17 Gene Transcriptionresembles human multiple sclerosis (Baxter, 2007). The severity
of EAE diseases was significantly reduced in CNS2-deficient
mice (Figure 7A). In our two independent EAE assays, only 1 of
the 10 CNS2-deficient mice reached score 2. However, 9 of
the 11 WT mice reached scores 2.5 or above. In addition, the
disease onset was also delayed in CNS2-deficient mice (Fig-
ure 7A). These results are consistent with the phenotype of
EAE diseases in IL-17-deficient mice (Komiyama et al., 2006;
Yang et al., 2008a). Interestingly, two of the five diseased
CNS2-deficient mice showed signs of recovery on day 9 after
second immunization and one of them was fully recovered on
day 10 (data not shown). However, none of the nine diseased
WT mice showed any signs of recovery. The phenotype of earlyrecovery from EAE was also observed in IL-17F-deficient mice
(Komiyama et al., 2006; Yang et al., 2008a).
We then examined the expression of IL-17 and IL-17F in EAE
mice. There was 3-fold reduction in the percentages of IL-17+
cells in the central nervous system and2.3-fold reduction in the
spleens of CNS2-deficient mice when compared with WT mice
(Figure 7B). A dramatic reduction of IL-17 secretion was also
observed by ELISA assays in the splenocytes of CNS2-deficient
mice in EAE experiments (Figure 7C). Consistent with the in vitro
differentiation results, IL-17F expression was also partially
reduced as determined by ELISA assays (Figure 7C) or by intra-
cellular staining in CNS2-deficient mice (Figure S6). Interestingly,
although the percentages of IFN-g+ cells were not significantlyFigure 5. Regulation of IL-17 or IL-17F Expression
by CNS2 in Unchallenged Mice
The expression of IL-17 in memory CD4+ T cells (gated on
CD4+CD62LloCD44hiCD25) (WT = 4, KO = 3) or IL-17 and
IL-17F in gd T cells (gated on gd+ TCR) (WT = 4, KO = 4)
and LTi-like cells (gated on CD4+CD3) (WT = 5, KO = 4)
was analyzed by intracellular staining after ex vivo re-
stimulation. The staining data are shown in the left panel,
and the statistical data of media fluorescence intensity
(MFI) and intracellular staining (for gd T and LTi-like cells)
or intracellular staining data alone (for memory CD4+
T cells) are shown in the corresponding right panel as
mean ± SD (standard deviation). All the experiments were
repeated two to three times with consistent results. See
also Figure S4.
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Figure 6. Regulation of IL-17 or IL-17F by CNS2
in Innate and Adaptive Immune Responses
(A) Age-matched WT and CNS2-deficient mice (n = 5 or 6)
were intranasally challenged with FAP twice on day 1 and
then analyzed on day 2 for IL-17 and IL-17F expression in
lung gd T cells (left: intracellular staining data) or in the lung
tissues (right: real-time RT-PCR data), shown as mean ±
SD.
(B) Age-matched WT and CNS2-deficient mice (n = 5)
were immunized with MOG35-55 peptides on day 1 and
then analyzed on day 8 for IL-17 and IFN-g production.
Left: intracellular staining data from MOG35-55 restimu-
lated splenocytes. Middle: statistics of IL-17 staining data
in spleens (Sp) or draining lymph nodes (dLN). Right:
statistics of the total number of IL-17+ cells in Sp or dLN
(mean ± SD).
See also Figure S5.
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Requirement of CNS2 in Il17 Gene Transcriptionaffected by the deletion of CNS2, the IL-17+ and IFN-g+ double-
positive cells were completely absent in CNS2-deficient mice
(Figure 7B). These data pinpoint the importance of CNS2 in regu-
lating the expression of both IL-17 and IL-17F in vivo and Th17
cell-related autoimmune diseases.
DISCUSSION
In previous studies, we have identified a total of eight conserved
noncoding sequences (CNS1–CNS8) located in the Il17-Il17f
locus, which spread over 120 kb in the genome. Among these
CNS sites, CNS2 is suggested to regulate IL-17 gene expression
(Okamoto et al., 2010; Schraml et al., 2009; Yang et al., 2008b;28 Immunity 36, 23–31, January 27, 2012 ª2012 Elsevier Inc.Zhang et al., 2008). However, the involvement of other CNS
elements in regulating Th17 cell genes is also implicated. For
example, CNS3–CNS5 all undergo hyperacetylation in Th17 cells
and are shown to interact with Batf—a transcription factor that is
crucial for Th17 cell differentiation (Schraml et al., 2009; Akimz-
hanov et al., 2007). Moreover, there are more than six DNase I
hypersensitivity sites located in the Il17-Il17f gene locus other
than CNS2 in Th17 cells (Mukasa et al., 2010). However, none
of these cis elements have been examined in terms of their
function in CD4+ T cells in vitro and in vivo. In this study, we
characterized the function of a cis-acting element, CNS2. By
using luciferase reporter gene assays in primary T cells, we
demonstrate that CNS2 functions in a cell type-specific mannerFigure 7. CNS2-Deficient Mice Were Resistant
to EAE
(A) WT and CNS2-deficient mice were immunized twice
with MOG35-55. Mean clinical scores are shown versus
days after second MOG immunization. Shown here is the
combinational result of two EAE experiments (the total
number of mice used: WT = 12, KO = 11).
(B) The IL-17 and IFN-g level was determined in the infil-
trates of central nervous system (CNS) and the spleno-
cytes of MOG35-55-immunized mice. Left: intracellular
staining; right: statistic of the staining data.
(C) IL-17 and IL-17F expression in the splenocytes of
immunized mice was determined by ELISA after restim-
ulation with MOG35-55 peptide.
A total of six WT and five to six KO mice were analyzed in
(B) and (C). All the data are shown as mean ± SD. See also
Figure S6.
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Requirement of CNS2 in Il17 Gene Transcriptionin driving not only the Il17 but also the Il17f gene transcription.
Moreover, CNS2 induced transcription in Th17 cells even when
fused to Il4 or Ifng gene promoters, supporting the fact that
CNS2 but not the Il17 and Il17f gene promoters dictates Th17
cell-specific transcription.
To examine the function of CNS2 in vivo, we generated CNS2-
deficient mice and found that CNS2 controlled the expression of
IL-17 in Th17 cells generated both in vitro and in vivo, as well as
in memory CD4+ T cells. However, the expression of IL-17F was
only partially dependent on CNS2, as shown by the fact that
deficiency of CNS2 led to 45%–70% reduction of IL-17F
expression in in-vitro- and in-vivo-generated Th17 cells. In
contrast, in gd T and LTi-like cells, CNS2 mainly controlled the
per-cell protein expression of IL-17 but not the frequency of
IL-17+ population. The IL-17F expression, however, may be
even increased in innate immune cells in CNS2-deficient mice.
One exception to our findings is the Th17 (CD4+IL-17+) cells
present in the gut, which showed a similar CNS2-dependent
regulatory pattern to innate immune cells in terms of IL-17 or
IL-17F expression. These gut-resident Th17 cells are shown to
constitutively express RORgt and readily produce IL-17 upon
stimulation (Ivanov et al., 2006) and might represent a distinct
Th17 cell population.
To understand the mechanism underlying the regulation of
IL-17 and IL-17F by CNS2, we performed a 3C analysis and
noticed that CNS2 can directly interact with the Il17 and Il17f
gene promoters only in Th17 cells. The looping of both Il17 and
Il17f genes together to CNS2 provides a physical basis for how
these two genes are coordinately expressed in Th17 cells,
whereas the lineage-specific looping suggests that this partic-
ular chromosomal configuration forms during Th17 cell differen-
tiation and may involve lineage-specific transcription factors.
This is in contrast to Th2 cells in which the Th2 LCR interacts
with the cytokine gene promoters before the commitment of
CD4+ T cells to Th2 cell lineage or even exists in other T cell
lineages (Spilianakis and Flavell, 2004). This difference may
explain that fact that a basal level of IL-4, but not IL-17, is detect-
able in naive CD4+ T cells upon stimulation (Nakamura et al.,
1997). This study therefore provides a distinct looping mecha-
nism for the function of trans-acting factors in regulating Th17
cell gene transcription.
Chromatin remodeling in CD4+ T cells has been extensively
studied because of its essential role in controlling helper T cell
development and lineage plasticity. However, the involving
cis-acting elements remain poorly understood in Th17 cells.
Our study revealed an essential role of RORgt in mediating
permissive histone remodeling of the Il17-Il17f gene locus in
Th17 cells. RORgt critically controlled the permissive histone
marker H3Ac at CNS2 and the Il17 promoter region in Th17 cells,
as well as the repressive histone marker H3K27me3 and to a
less extent at the Il17fp region. This result indicates an essential
role of RORgt in the chromatin remodeling at CNS2. CNS2
then functions by controlling the chromatin structure at the
Il17 or Il17f promoter region. Retroviral overexpression assays
showed that CNS2 was indispensible for the function of RORs
in mediating IL-17 expression. Taken together, these results
suggest that the interaction between CNS2 and RORgt may
play an important role in activation of the transcription at the
Il17-Il17f gene locus.Interestingly, we found that CNS2 was bound by histone
remodeling enzymes p300 and JMJD3 in Th17 cells, which are
shown to induce permissive acetylation of histone H3 or to
remove the repressive histone marker H3K27me3, respectively
(Agger et al., 2007; De Santa et al., 2007;Wang et al., 2008; Xiang
et al., 2007), suggesting that a histone remodeling enzymatic
complex associates with CNS2 in Th17 cells, possibly by the
interaction between CNS2 and RORgt. The looping of CNS2
with the promoters thus is able to bring CNS2-associated
histone remodeling enzymes to the promoters for chromatin
activation at distal regions.
In summary, this study provides a molecular basis of how
cis- and trans-acting factors may function together in Th17
cells to drive selective cytokine gene expression. The commit-
ment to Th17 cell lineage may begin by inducing one or more
crucial early transcription factors, such as ROR factors, which
bind to CNS2 and the Il17 and Il17f promoters to induce loop-
ing of the cytokine locus by interacting with each other or the
basic transcriptional machinery assembled on the promoter
regions. During this process, chromatin remodeling enzymes
are recruited to CNS2 and possibly other cis elements and
cause permissive and lineage-specific chromatin remodeling
of the Th17 cytokine locus. The opening of the Il17-Il17f locus
then leads to binding of more cell type-specific trans-acting
factors, which interact with the basic transcriptional machinery
because of close spatial proximity and then activate gene
transcription in a robust and lineage-specific manner. Consid-
ering the importance of CNS2 in regulating IL-17 and IL-17F,
characterization of the transcription factors and other cis
elements that associate with CNS2 may reveal additional
mechanisms underlying the differentiation of Th17 cells, a
proinflammatory effector Th cell subset important in many
inflammatory diseases.EXPERIMENTAL PROCEDURES
Primers
All the primers used for ChIP-PCR, mutagenesis, luciferase reporter, CNS2-
targeting plasmid construction, and genotyping are listed in Table S1. The
real-time RT-PCR primers used to quantify Il17, Il17f, Il21, RORa, RORgt,
and b-actin were described previously (Yang et al., 2008b).
Mice
The CNS2-targeting plasmid was generated by cloning the sequences flank-
ing the CNS2 site into pEASY-Flox vector that uses NeoR as positive and
thymidine kinase as negative selection markers (Figure S2A). CNS2-deficient
mice were generated by replacing the CNS2 fragment with a NeoR gene
cassette flanked by Floxp sites via the 129/TC1 embryonic stem cell line (Fig-
ure S2A). Targeted embryonic stem cell clones were selected and injected
into C57BL/6 blastocysts to generate chimeras. High percentage chimeras
were bred with C57BL/6 mice for germline transmission. The CNS2+/
mice were obtained by crossing with the CMV-Cre strain to remove the
NeoR cassette. The deletion of CNS2 alleles was detected by PCR (Fig-
ure S2B). Homozygous WT and CNS2-deficient animals on the same
129 3 C57BL/6 F1 mixed background were bred and used in experiments.
All the mice were housed in the SPF animal facility at the M.D. Anderson
Cancer Center and the animal experiments were performed at the age of
6–8 weeks with the use of protocols approved by the Institutional Animal
Care and Use Committee.
Rorc/ (RORg-deficient) mice were generated before (Kurebayashi et al.,
2000) and their splenocytes were used for isolation of naive CD4+ T cells in
this study.Immunity 36, 23–31, January 27, 2012 ª2012 Elsevier Inc. 29
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Requirement of CNS2 in Il17 Gene TranscriptionLuciferase Reporter Assays
The Il17, Il17f, and Ifng promoters, without or together with CNS2, were cloned
into PGL3 luciferase reporter plasmid. The ROR binding sites in CNS2 were
mutated by site-directed mutagenesis. The PGL3-Il4p reporter construct
was made before (Lee et al., 2001).For all the reporter constructs, CNS2
was cloned into the MluI and XhoI sites and the promoters were cloned into
XhoI and HindIII sites in PGL3 plasmid. All the primers used for cloning and
mutagenesis were listed in Table S1. Naive CD4+ T cells were isolated from
C57BL/6 mice and differentiated under Th1 and Th17 cell conditions. On
day 3, the cells were transfected with different luciferase reporter constructs
together with a control Renilla luciferase reporter plasmid by using a Mouse
T Cell Nucleofector Kit (LONZA, cat# VPA-1006) and Amaxa Nucleofector I
(Amaxa Biosystem) according to manufacturer’s instructions. The dual-
luciferase reporter system (Promega) was used to examine firefly and Renilla
luciferase activity. Renilla luciferase was used to normalize transfection effi-
ciency and luciferase activity.
Isolation of Different Immune Cells and T Cell Differentiation
For Th cell differentiation, naive T cells were isolated by sorting CD4+
CD25CD62LhiCD44lo cells from spleens and lymph nodes, differentiated
under several T helper cell conditions, and analyzed as described (Nurieva
et al., 2007; Yang et al., 2008b). Th0 cells (for retroviral infection): 0.5 mg ml1
anti-CD3 (plate-bound), 0.5 mg ml1 anti-CD28 (soluble), 10 mg ml1 anti-IL4
(11B11), 10 mg ml1 anti-IFN-g (XMG), and 30 U ml1 IL-2. Th1 cells: 1 mg ml1
anti-CD3 (plate-bound), 1 mgml1 anti-CD28 (plate-bound), 10 mgml1 anti-IL4
(11B11), 10 ng ml1 IL-12, and 30 U ml1 IL-2. Th2 cells: 0.5 mg ml1 anti-CD3
(plate-bound), 0.5 mg ml1 anti-CD28 (soluble), 10 mg ml1 anti-IFN-g,
10 ng ml1 IL-4, and 30 U ml1 IL-2. iTreg cells: 1 mg ml1 anti-CD3 (plate-
bound), 1 mg ml1 anti-CD28 (plate-bound), 10 mg ml1 anti-IL4 (11B11),
10 mg ml1 anti-IFN-g, and 2.5 ng ml1 TGF-b. Th17 cells: 1 mg ml1 anti-
CD3 (plate-bound), 1 mg ml1 anti-CD28 (plate-bound), 15 ng ml1 IL-6, and
2.5 ng ml1 TGF-b. When indicated, 50 ng ml1 IL-23, 10 ng ml1 tumor
necrosis factor (TNF)-a, and 10 ng ml1 IL-1b were used for optimal Th17 cell
differentiation.
Memory CD4+, gd T, and LTi-like cells were isolated by sorting or gating on
CD4+CD62LloCD44hiCD25, gd+ TCR, or CD4+CD3 cells from spleens and
lymph nodes, respectively, and analyzed by intracellular staining after phorbol
12-myristate 13-acetate (PMA) and ionomycin restimulation in the presence of
Golgi-stop or by real-timeRT-PCR after ex vivo restimulation. IELs and LP cells
were isolated from the small intestine as previously described (Goodman and
Lefranc¸ois, 1988; Laky et al., 1997), and the cells was analyzed by intracellular
staining after PMA and ionomycin restimulation in the presence of Golgi stop.
Chromosome Conformation Capture Assays
The chromosome conformation capture (3C) assays were performed as
described with minor modifications (Tolhuis et al., 2002). PstI and NsiI were
used to generate restriction fragments of the Il17-Il17f locus in Th1 and Th17
cells. The ligation of CNS2 to the Il17 and Il17f promoters was detected by
PCR amplification with primers shown in Table S1. Undigested C57BL/6
genomic DNA was used as a negative control for the PCR reactions.
Retrovrial Transduction
RORa (GenBank accession XM_903197) and RORgt (GenBank accession
AJ132394) were cloned into bicistronic retroviral vector pMIG-hCD2 contain-
ing IRES-regulated human CD2 as described (Nurieva et al., 2007; Yang
et al., 2008b). Naive CD4+ T cells were activated with 0.5 mg ml1 anti-CD3
(plate-bound), 0.5 mg ml1 anti-CD28 (soluble), and differentiated under Th0
and Th17 cell conditions. On day 1, the cells were infected by retroviruses
RORa-hCD2, RORgt-hCD2, or control empty vector pMIG-hCD2. On day 4,
the cells were restimulated with PMA and ionomycin in the presence of
Golgi-stop for 5 hr, stained for surface marker hCD2 first, and then stained
for IL-17 and IL-17F intracellularly.
ChIP-PCR Assays
Cells were first cross-linked with 2% paraformadehyde for 10 min at 37C and
sonicated, and then the DNA-protein complexes were isolated with a ChIP
assay kit (Millipore, Cat# 17-295) according to manufacturer’s instructions
with antibodies against p300 (SantaCruz), acetylated histone H3 (H3Ac)30 Immunity 36, 23–31, January 27, 2012 ª2012 Elsevier Inc.(Millipore), trimethylated histone H3-K27 (H3K27me3) (Millipore), RNA
Polymerase II (SantaCruz), or JMJD3 (Abcam). The precipitated DNA was
quantified by real-time PCR with primers listed in Table S1. The results were
normalized relative to the input control.
Quantitative Real-Time RT-PCR
Total RNA was isolated from T cells with the use of Trizol reagent (Invitrogen)
according to manufacturer’s instructions. cDNAs were synthesized with
Superscript reverse transcriptase and oligo(dT) primers (Invitrogen) and
analyzed with an iCycler Optical System and an iQ SYBR green real-time
PCR kit (Bio-Rad). The data were normalized to a b-actin control.
Allergic Lung Inflammation
Age-matched CNS2-deficient and their WT control mice were challenged
intranasally twice with an allergenic fungal proteinase (FAP) derived from
Aspergillus oryzae on day 1 at a dosage of 7 mg FAP and 43 mg OVA in 50 ml
PBS per mice, and then we analyzed IL-17 and IL-17F expression in the
lung tissues or lung gd T cells on day 2 as described (Kiss et al., 2007; Yang
et al., 2008a).
MOG Immunization and Induction of EAE
Both MOG immunization and EAE induction were performed by immunizing
mice with 300 mg MOG35-55 peptide (amino acids 35–55; MEVGWYRSPFS
ROVHLYRNGK) emulsified in CFA and analyzed as previously described
(Nurieva et al., 2007; Yang et al., 2008b). The disease scores were assigned
on a scale of 0–5 as follows: 0, none; 1, limp tail or waddling gait with tail
tonicity; 2, wobbly gait; 3, hindlimb paralysis; 4, hindlimb and forelimb
paralysis; 5, death.
Calculations and Statistic Analysis
All our in vitro data were repeated at least 2–5 times with consistent results.
When indicated, the statistical significance was determined by Student’s
t test (*p < 0.05; **p < 0.03; ***p < 0.01).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and one table and can be
found with this article online at doi:10.1016/j.immuni.2011.10.019.
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